Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 36 | 57 | 244 | 605 | 606 |
| Cost of Goods | 70 | 89 | 530 | 493 | 537 |
| Gross Profit | -34 | -32 | -286 | 112 | 69 |
| Operating Expenses | 973 | 1,605 | 3,365 | 4,425 | 6,833 |
| Operating Income | -937 | -1,548 | -3,121 | -3,820 | -6,227 |
| Interest Expense | 1,412 | 1,763 | 1,106 | 1,895 | 1,317 |
| Other Income | 428 | 4,327 | -6,469 | 1,745 | 642 |
| Pre-tax Income | -1,921 | 1,016 | -10,696 | -3,970 | -6,902 |
| Net Income Continuous | -1,921 | 1,016 | -10,696 | -3,970 | -6,902 |
| Net Income | $-1,921 | $1,016 | $-10,696 | $-3,970 | $-6,902 |
| EPS Basic Total Ops | -0.58 | 1.95 | 997.64 | -20,516.67 | -4,949,483.00 |
| EPS Basic Continuous Ops | -0.58 | 2.20 | -972.36 | -16,297.21 | -2,875,833.00 |
| EPS Diluted Total Ops | -0.58 | 0.01 | 997.64 | -20,516.67 | -4,949,483.00 |
| EPS Diluted Continuous Ops | -0.58 | 0.02 | -972.36 | -16,297.21 | -2,875,833.00 |
| EPS Diluted Before Non-Recurring Items | -0.58 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-719 | $-686 | $-2,908 | $-2,597 | $-5,173 |